Our main investment focus areas are Alternative Proteins, Renewable Energy, and Medicine Packing.
1、Alternative Proteins
DFP Capital began to pay attention to the global alternative protein industry in 2018. After investigation and research, it finally worked with well-known industry experts and partners to establish the Lever VC New Protein Fund in 2019. The Lever VC New Protein Fund is the world's leading fund focusing on animal welfare and An investment fund specializing in venture capital for the animal protein substitutes industry, with a first-phase scale of US$80 million, Officially operational in 2020. Using Lever VC as a platform to invest in global animal protein alternatives reflects DFP Capital's social responsibility to care for the Earth's environment, human health, and animal welfare.
The highest return on investment project among invested enterprises is TurtleTree Labs in Singapore.
Founded in January 2019, Turtle Tree Labs has long-term plans to use cell culture to produce milk of humans, cows and other mammals. The immediate goal is to use precision fermentation technology to produce key nutrients in milk.
In October 2023, its laboratory in California, USA, received a safety certificate from the FDA for its lactoferrin, and since then it has started its journey of commercialization. This is the world's first sustainably produced lactoferrin (LF+).Lactoferrin is a rather scarce and precious ingredient, which sells for more than $1,500 per kilogram in the market. Lactoferrin can improve the nutritional value of food and enhance the human immunity.
The scarcity of lactorferrin can be appreciated from the composition of milk:Lactoferrin is a minority within a minority within the entire range of ingredients which make up milk. In milk, protein accounts for only 3.3%, and is again mainly casein (more than 80%) and whey protein (about 18%). Of the whey protein, 50% is ß-lactoglobulin, 20% is α-lactobumin, with the rest being made up of serum albumin, immunoglobulin, lactoferrin, transferrin, and many minor proteins and enzymes.
The company has raised four rounds of capital, which totals $400 million. By comparison, Mosa Meat, founded in 2013, has to date raised just $100 million while Good Meat, which was founded in 2016, has raised nearly $300 million. This testifies the high interest of Turtle Tree Labs from investors around the world.
The company's founders, Lin Fengru and Max Rye, have actively participated in seminars in the alternative protein industry and have been interviewed by many online and offline media.
The company has received some major awards, which underlies its value perceived by the award givers and international community of investors.
√ In July 2020, TurtleTree Labs participated in The Liveability Challenge 2020 and won the top prize, pocketing S$1 million (US$718,80) from the event’s organiser Temasek Foundation. This annual event seeks solutions to significant challenges faced by Southeast Asian cities.
√ In October 2020 the company signed up for the Entrepreneurship World Cup (EWC) and won the highest award, US$500,000 from the organiser, the Saudi government. As many as 175,000 startups from more than 200 countries completed in this contest.
2、Renewable Energy
Against the backdrop of increasingly prominent global environmental issues, the new energy industry is facing enormous development opportunities. DFP Capital will be committed to investing in projects in the fields of renewable energy, clean technology, and energy storage. We believe that by investing in and supporting new energy projects, we can contribute to global energy transformation and achieve sustainable economic returns.
3、Medicine Packing
With the rapid development of the global pharmaceutical industry, Medicine Packing, as one of the key links, plays a crucial role in the protection and safety of drugs. DFP Capital is committed to investing in and supporting innovative medicine packing solutions to improve the quality and safety of drugs. In the future, we will look for medicine packing projects with innovative technologies, high-quality standards, and broad market potential.